GERN Geron Corporation Stock Quote

GERN [NASD]

Index	-	P/E	-	EPS (ttm)	-0.36	Insider Own	0.10%	Shs Outstand	332.07M	Perf Week	-9.93%
Market Cap	475.73M	Forward P/E	-	EPS next Y	-0.39	Insider Trans	0.00%	Shs Float	307.85M	Perf Month	-13.01%
Income	-118.40M	PEG	-	EPS next Q	-0.09	Inst Own	49.50%	Short Float	7.19%	Perf Quarter	23.30%
Sales	1.40M	P/S	339.81	EPS this Y	-27.20%	Inst Trans	31.11%	Short Ratio	8.77	Perf Half Y	-17.53%
Book/sh	0.29	P/B	4.38	EPS next Y	0.00%	ROA	-52.30%	Target Price	4.00	Perf Year	-7.97%
Cash/sh	0.44	P/C	2.86	EPS next 5Y	5.00%	ROE	-85.80%	52W Range	0.99 - 2.23	Perf YTD	4.10%
Dividend	-	P/FCF	-	EPS past 5Y	-13.80%	ROI	-64.70%	52W High	-41.93%	Beta	0.99
Dividend %	-	Quick Ratio	3.80	Sales past 5Y	-25.70%	Gross Margin	-	52W Low	30.82%	ATR	0.12
Employees	69	Current Ratio	3.80	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	44.70	Volatility	8.72% 8.72%
Optionable	Yes	Debt/Eq	0.51	EPS Q/Q	-5.40%	Profit Margin	-	Rel Volume	0.48	Prev Close	1.27
Shortable	Yes	LT Debt/Eq	0.51	Earnings	May 09 AMC	Payout	-	Avg Volume	2.52M	Price	1.29
Recom	1.60	SMA20	-7.47%	SMA50	-6.87%	SMA200	-2.23%	Volume	899,399	Change	1.97%

Nov-02-21

Initiated

Robert W. Baird

Outperform

Feb-18-21

Resumed

B. Riley Securities

Buy

Aug-03-20

Initiated

Stifel

Buy

Nov-19-19

Resumed

B. Riley FBR

Buy

Sep-03-19

Initiated

H.C. Wainwright

Buy

Aug-15-19

Initiated

Cantor Fitzgerald

Overweight

Apr-09-19

Upgrade

Needham

Hold → Buy

Jan-31-19

Upgrade

B. Riley FBR

Neutral → Buy

$1.50 → $3.25

Oct-02-18

Downgrade

B. Riley FBR

Buy → Neutral

$5.75 → $1.50

Jul-05-18

Initiated

B. Riley FBR, Inc.

Buy

$5.75

Sep-13-16

Reiterated

FBR Capital

Outperform

$6 → $5

Sep-13-16

Reiterated

FBR & Co.

Outperform

$6 → $5

Dec-07-15

Reiterated

Piper Jaffray

Overweight

$5 → $10

Apr-21-15

Initiated

Oppenheimer

Outperform

$5.50

Jun-12-14

Upgrade

MLV & Co

Hold → Buy

$2 → $4.25

Mar-12-14

Downgrade

MLV & Co

Buy → Hold

$9 → $2

Dec-10-13

Upgrade

Needham

Hold → Buy

$10

Dec-10-13

Reiterated

MLV & Co

Buy

$8 → $9

Nov-08-13

Reiterated

MLV & Co

Buy

$6.50 → $8

Oct-16-13

Initiated

MLV & Co

Buy

$6.50

May-23-22 12:26PM	Regeneron's (REGN) Evkeeza Positive in Late-Stage Study Zacks
11:46AM	Novartis (NVS) Cosentyx Gets Positive CHMP Opinion for JIA Zacks
May-19-22 04:30PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
12:15PM	Endo (ENDP) Crashes 46.54% as it Looks to Restructure Debt Zacks
May-17-22 04:30PM	Geron to Present at the H.C. Wainwright Global Investment Conference Business Wire
11:33AM	Bristol Myers (BMY) Phase III CheckMate -901 Study Disappoints Zacks
11:30AM	Gilead (GILD) HIV Studies Removed From FDA's Clinical Hold Zacks
May-10-22 12:21PM	Why Geron Stock Is Soaring Today Motley Fool +20.33%
02:09AM	Geron (GERN) Q1 2022 Earnings Call Transcript Motley Fool
May-09-22 05:55PM	Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates Zacks -5.38%
04:05PM	Geron Corporation Reports First Quarter 2022 Financial Results Business Wire
May-02-22 04:30PM	Geron to Announce First Quarter 2022 Financial Results on May 9, 2022 Business Wire +5.67%
May-01-22 08:39AM	Shareholders in Geron (NASDAQ:GERN) are in the red if they invested five years ago Simply Wall St.
Apr-21-22 04:30PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Apr-07-22 05:51AM	3 of the Fastest-Growing Stocks on the Planet Through 2026 Motley Fool
Apr-06-22 04:30PM	Geron to Present at the 21st Annual Needham Virtual Healthcare Conference Business Wire +5.77%
Apr-01-22 04:15PM	Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants Business Wire +11.76%
Mar-30-22 05:24PM	Why Geron's Shares Rose 23.4% on Wednesday Motley Fool +25.00%
02:25AM	Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants Business Wire
Mar-29-22 04:01PM	Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants Business Wire +5.79%
Mar-17-22 04:30PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire +13.59%
Mar-10-22 09:00PM	Geron (GERN) Q4 2021 Earnings Call Transcript Motley Fool
04:06PM	Geron Corporation Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Milestones Business Wire
Mar-03-22 04:30PM	Geron to Announce Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022 Business Wire
Jan-31-22 10:18AM	Could The Geron Corporation (NASDAQ:GERN) Ownership Structure Tell Us Something Useful? Simply Wall St.
Jan-26-22 10:05AM	Karyopharm's (KPTI) Eltanexor Gets Orphan Drug Tag for MDS Zacks
Jan-21-22 07:30AM	Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference Business Wire
Jan-20-22 04:30PM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jan-04-22 05:01PM	Geron to Present at the H.C. Wainwright BioConnect Conference Business Wire -6.11%
Dec-16-21 04:30PM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Dec-14-21 04:30PM	Geron Reports Presentations at American Society of Hematology Annual Meeting Business Wire
Dec-02-21 07:30AM	Geron Announces Appointment of Chief Business Officer Business Wire
Nov-18-21 04:30PM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Nov-12-21 07:30AM	Geron to Present at the Stifel 2021 Virtual Healthcare Conference Business Wire
Nov-09-21 09:05PM	Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates Zacks
06:00PM	Geron Presents Investor Event Highlights Business Wire
Nov-04-21 09:12AM	Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting Business Wire
Oct-31-21 10:44AM	Is Geron (NASDAQ:GERN) Using Debt In A Risky Way? Simply Wall St.
Oct-28-21 03:06PM	Analysts Estimate Geron (GERN) to Report a Decline in Earnings: What to Look Out for Zacks +8.28%
Oct-25-21 04:30PM	Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat Business Wire
Oct-21-21 04:30PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Oct-18-21 07:30AM	Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes Business Wire
Oct-15-21 04:05PM	Geron to Host a Virtual Investor Event in November Business Wire
Oct-11-21 04:30PM	Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology Business Wire
Sep-16-21 04:30PM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Sep-01-21 04:30PM	Geron Announces September Investor Conference Presentation Webcasts Business Wire
Aug-28-21 08:01AM	Here's What Investors Need From Geron Motley Fool
Aug-19-21 04:30PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Aug-17-21 08:28AM	The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga +6.67%
05:00AM	Geron (GERN) Q2 2021 Earnings Call Transcript Motley Fool
Aug-16-21 05:25PM	Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:06PM	Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023 Business Wire
Aug-05-21 04:30PM	Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021 Business Wire
Aug-02-21 06:09AM	Do Institutions Own Geron Corporation (NASDAQ:GERN) Shares? Simply Wall St.
Jul-29-21 03:05PM	Earnings Preview: Geron (GERN) Q2 Earnings Expected to Decline Zacks -5.38%
Jul-22-21 04:45PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jun-21-21 12:15PM	Geron (GERN) Soars on Imetelstat Data for Myelofibrosis Zacks -7.10%
08:36AM	Do Options Traders Know Something About Geron (GERN) Stock We Don't? Zacks
Jun-18-21 11:40AM	Why Geron Stock Is Soaring Today Motley Fool +29.79%
10:04AM	Geron Skyrockets on Bone Marrow Cancer Treatment Trial TheStreet.com
06:31AM	Geron Stock Trading Is Higher On Reinforcing Imetelstat's Approach For Myelofibrosis Treatment, With Data Publication In Journal Benzinga
Jun-17-21 04:30PM	Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology Business Wire
Jun-14-21 04:30PM	Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress Business Wire
May-12-21 10:56AM	Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress Business Wire
May-11-21 02:01AM	Geron (GERN) Q1 2021 Earnings Call Transcript Motley Fool +11.20%
May-10-21 05:55PM	Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates Zacks -6.02%
04:05PM	Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights Business Wire
May-04-21 10:37AM	Here's Why It's Unlikely That Geron Corporation's (NASDAQ:GERN) CEO Will See A Pay Rise This Year Simply Wall St.
May-03-21 04:30PM	Geron to Announce First Quarter 2021 Financial Results on May 10, 2021 Business Wire
Apr-27-21 04:36AM	SHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged to Contact the Firm GlobeNewswire
Apr-22-21 04:30PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Apr-20-21 04:01PM	GERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, P.C. GlobeNewswire
Apr-19-21 09:30AM	SHAREHOLDER ALERT: Geron Corporation (GERN) Officers and Directors Under Investigation for False Statements and Insider Trading PR Newswire
Apr-18-21 08:00AM	Lifshitz Law Firm, P.C. Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, Inc. (NYSE: JELD), and Oracle Corporation (NYSE: ORCL) GlobeNewswire
Apr-14-21 09:40AM	Geron (GERN) Begins Phase III Myelofibrosis Study on Imetelstat Zacks +5.59%
Apr-13-21 07:30AM	Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis Business Wire
Mar-18-21 04:45PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Mar-12-21 12:06PM	Why Geron Corporation Stock Is Falling Today Motley Fool -8.99%
08:00AM	Gene editing will boost intelligence within a few decades Yahoo Finance Video
03:00AM	Geron (GERN) Q4 2020 Earnings Call Transcript Motley Fool
Mar-11-21 04:10PM	Geron Corporation Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights Business Wire
07:00AM	Influencers with Andy Serwer: Walter Isaacson Yahoo Finance Video
Mar-10-21 10:08AM	Geron's Earnings Outlook Benzinga
Mar-04-21 12:30PM	Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Mar-01-21 04:45PM	Geron to Announce Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021 Business Wire
Feb-18-21 04:45PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Feb-07-21 03:54AM	Is Geron (NASDAQ:GERN) Weighed On By Its Debt Load? Simply Wall St.
Jan-21-21 04:45PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jan-14-21 04:45PM	Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference Business Wire
Dec-17-20 01:25PM	Is GERN A Good Stock To Buy Now? Insider Monkey
Dec-11-20 08:30AM	Geron Announces Opening of IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis Business Wire
Dec-10-20 08:30AM	Geron Announces Fifty Percent Enrollment Milestone in IMerge Phase 3 Clinical Trial in Lower Risk MDS Business Wire
Dec-07-20 06:45PM	Geron Reports Ten Imetelstat Presentations at American Society of Hematology Annual Meeting Business Wire
Nov-19-20 04:30PM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Nov-10-20 04:30PM	Geron to Present at the Stifel Virtual Healthcare Conference Business Wire
Nov-08-20 07:51AM	Time To Worry? Analysts Just Downgraded Their Geron Corporation (NASDAQ:GERN) Outlook Simply Wall St.
Nov-06-20 10:31AM	Geron (GERN) Q3 2020 Earnings Call Transcript Motley Fool
Nov-05-20 07:20PM	Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:25PM	Recap: Geron Q3 Earnings Benzinga
04:05PM	Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events GlobeNewswire

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
EASTHAM KARIN	Director	Apr 20	Option Exercise	1.41	35,000	49,350	74,047	Apr 21 08:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience